Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, (Therapeutic Vaccines and Preventive Vaccines), Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

Published: December 2015
No. of Pages: 126
   

Growing Focus Cancer Therapies with Fewer Side Effects Is the Major Drivers of the Immunotherapy Drugs Market

The immunotherapy drugs market is broadly segmented on the basis of type of drugs and geographic region. The major type of immunotherapy drugs studied in the report includes antibodies (monoclonal and polyclonal), interferon (alpha), interleukins, vaccines, and checkpoint inhibitors. Among these types of drugs, monoclonal antibodies segment is expected to command the largest share while checkpoint inhibitors is expected to grow at the highest rate. This high growth rate is attributed to the technological advancement and higher efficacy of checkpoint inhibitors.

The immunotherapy drugs market, by geography, is classified into North America, Europe, Asia-Pacific, and Rest of the World. The North American geographic segment will account for the largest share of the global immunotherapy drugs market in 2015, followed by the Europe geographic segments. The Asia-Pacific segment is expected to account for highest CAGR of the immunotherapy drugs market in 2015. The major drivers for the growth of this market are increasing incidence of different types of cancer; focus on targeted therapies with fewer side effects and quicker drug approval processes.

From an insight perspective, this research report focuses on qualitative data, market size, growth of various segments and sub segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data of various segments in this industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives by governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on the key players in the immunotherapy drugs market and the strategies adopted by them to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the immunotherapy drugs market. The report analyzes the immunotherapy drugs marketby technology, application, products & services, and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies and R&D activities in the immunotherapy drugs market
  • Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the immunotherapy drugs market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various products across geographies
  • Market Diversification: Exhaustive information on new products and services, untapped geographies, recent developments, and investments in the immunotherapy drugs market

Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, (Therapeutic Vaccines and Preventive Vaccines), Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Immunotherapy Drugs Market to Grow at A Rapid Rate
4.2 Global Immunotherapy Drugs Market Size
4.3 Geographical Snapshot of the Immunotherapy Drugs Market
4.4 Immunotherapy Drugs Market, By Type of Drug
4.5 Lifecycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.4 Drivers
5.4.1 Increasing Adoption of Targeted Therapy Over Traditional Therapy
5.4.2 Reduction in Overall Timeline and Cost for Drug Discovery
5.4.3 High Prevalence Rate of Lifestyle Diseases
5.4.4 Fast Track and Orphan Drug Designations
5.5 Restraints
5.5.1 High Cost of Immunotherapy Treatment
5.5.2 High Attrition Rate in the Product Development Cycle
5.6 Opportunities
5.6.1 Significant Growth Prospects in Developing Countries
5.6.2 Immunotherapy to Replace Chemotherapy as A First-Line Therapy
5.7 Challenges
5.7.1 Patent Expiries of Top-Selling Biologics

6  Cancer Immunotherapy Market- Industry Insights
6.1 Cancer Epidemiology
6.1.1 Estimated Incidence, Mortality, and 5-Year Prevalence: Men (2012)
6.1.2 Estimated Incidence, Mortality, and 5-Year Prevalence: Women
6.1.3 Estimated Incidence, Mortality, and 5-Year Prevalence: Both Sexes (2012)
6.2 Pricing and Reimbursement
6.2.1 U.S.
6.2.2 U.K.
6.2.3 France
6.2.4 Germany
6.2.5 Other European Countries
6.2.6 Japan
6.3 Pipeline
6.3.1 Phase 1
6.3.2 Phase I/II
6.3.3 Phase II
6.3.4 Phase II/III
6.3.5 Phase III
6.3.6 Application Submitted
6.4 Promising Molecules
6.5 Treatment Protocols and Line of Therapies
6.5.1 First Line Therapy
6.5.2 Second Line Therapy
6.5.3 Other Treatments

7 Immunotherapy Drugs Market, By Type of Drugs
7.1 Introduction
7.2 Monoclonal Antibodies
7.3 Interferons
7.4 Interleukins
7.5 Vaccines
7.6 Checkpoint Inhibitors

8 Global Immunotherapy Drugs Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.5 Rest of the World (RoW)

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Approvals
9.3.2 Agreements, Partnerships, and Collaborations
9.3.3 Acqusitions

10 Company Profiles
10.1 Introduction
10.2 F. Hoffmann-La Roche Ag
10.2.1 Business Overview
10.2.2 F. Hoffmann-La Roche Ag: Company Snapshot
10.2.3 Products Offered
10.2.4 Recent Developments
10.2.5 MnM View
10.3 Merck & Co., Inc.
10.3.1 Business Overview
10.3.2 Merck & Co., Inc.: Company Snapshot
10.3.3 Products Offered
10.3.4 Recent Developmen
10.3.5 MnM View
10.4 Novartis International Ag
10.4.1 Business Overview
10.4.2 Novartis International Ag: Company Snapshot
10.4.3 Products Offered
10.4.4 Recent Developments
10.4.5 MnM View
10.5 Glaxosmithkline Plc
10.5.1 Business Overview
10.5.2 Glaxosmithkline Plc: Company Snapshot
10.5.3 Product Offered
10.5.4 Recent Developments
10.5.5 MnM View
10.6 Amgen Inc.
10.6.1 Business Overview
10.6.2 Amgen Inc.: Company Snapshot
10.6.3 Products Offered
10.6.4 Recent Developments
10.6.5 MnM View
10.7 Bristol-Myers Squibb
10.7.1 Business Overview
10.7.2 Bristol-Myers Squibb: Company Snapshot
10.7.3 Products Offered
10.7.4 Recent Developments
10.8 ELI Lilly and Company
10.8.1 Business Overview
10.8.2 ELI Lilly and Company: Company Snapshot
10.8.3 Product Offered
10.8.4 Recent Developments
10.9 Celgene Corporation
10.9.1 Business Overview
10.9.2 Celgene Corporation: Company Snapshot
10.9.3 Products Offered
10.9.4 Recent Development
10.10 Seattle Genetics, Inc.
10.10.1 Business Overview
10.10.2 Seattle Genetics, Inc.: Company Snapshot
10.10.3 Product Offered
10.10.4 Recent Developments
10.11 Spectrum Pharmaceuticals, Inc.
10.11.1 Business Overview
10.11.2 Spectrum Phrmaceuticals, Inc.: Company Snapshot
10.11.3 Product Offered
10.11.4 Recent Developments

11 Appendix
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Introducing RT: Real-Time Market Intelligence
11.4 Available Customizations
11.5 Related Reports

List of Tables

Table 1 Global Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 2 Global Monoclonal Antibody Drugs Market Size, By Region,  2013-2020 (USD Million)
Table 3 North America: Monoclonal Antibody Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 4 Europe: Monoclonal Antibody Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 5 Asia-Pacific: Monoclonal Antibody Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 6 Global Interferon Drugs Market Size, By Region, 2013-2020 (USD Million)
Table 7 North America: Interferon Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 8 Europe: Interferon Drugs Market Size, By Country, 2013-2020 (USD Million)
Table 9 Asia-Pacific: Interferon Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 10 Global Interleukin Drugs Market Size, 2013-2020 (USD Million)
Table 11 Global Vaccines Market Size, By Region, 2013-2020 (USD Million)
Table 12 Global Vaccines Market Size, By Type, 2013-2020 (USD Million)
Table 13 North America: Vaccines Market Size, By Country, 2013-2020 (USD Million)
Table 14 Europe: Vaccines Market Size, By Country, 2013-2020 (USD Million)
Table 15 Asia-Pacific: Vaccines Market Size, By Country, 2013-2020 (USD Million)
Table 16 Global Checkpoint Inhibitor Drugs Market Size, By Region,  2013-2020 (USD Million)
Table 17 North America: Checkpoint Inhibitor Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 18 Europe: Checkpoint Inhibitor Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 19 Asia-Pacific: Checkpoint Inhibitor Drugs Market Size, By Country,  2013-2020 (USD Million)
Table 20 Global Immunotherapy Drugs Market Size, By Region,  2013–2020 (USD Million)
Table 21 North America: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 22 U.S.: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 23 Canada: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 24 Europe: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 25 Germany: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 26 U.K.: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 27 France: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 28 Italy: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 29 Spain: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 30 APAC: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 31 Japan: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 32 China: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 33 India: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 34 RoW: Immunotherapy Drugs Market Size, By Type of Drug,  2013–2020 (USD Million)
Table 35 Approvals, 2013–2015
Table 36 Agreements, Partnerships, and Collaborations, 2013–2015
Table 37 Acqusitions, 2013-2015

List of Figures

Figure 1 Research Design: Immunotherapy Drugs Market
Figure 2 Market Size Estimation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Immunotherapy Drugs Market Snapshot (2015 vs 2020): Checkpoint Inhibitors Will Grow at the Highest Rate in the Next Five Years
Figure 6 Global Immunotherapy Drugs Market, By Type of Drug, 2015
Figure 7 Global Immunotherapy Drugs Market Share, 2015
Figure 8 Changing Demograhics and Focus on Targeted Therapies to Drive Market Growth
Figure 9 Monoclonal Antibodies to Account for the Largest Share of the Market in 2015
Figure 10 APAC to Grow at the Highest Rate During the Forecast Period
Figure 11 Checkpoint Inhibitors Expected to Be the Fastest Growing Segment
Figure 12 North America and APAC Markets Hold Lucrative Growth Opportunities
Figure 13 Market Segmentation
Figure 14 Global Immunotherapy Drugs Market: Drivers, Restraints, Opportunities & Challenges
Figure 15 Monoclonal Antibodies Segment is Expected to Dominate the Market in 2015
Figure 16 Interferon Drugs Market in APAC to Witness Highest Growth From 2015 to 2020
Figure 17 Therapeutic Vaccines to Witness Higher Growth in the Forecast Period
Figure 18 North America to Witness Highest Growth in the Checkpoint Inhibitors Market From 2015 to 2020
Figure 19 Geographic Snapshot (2015): Asia-Pacific Will Be the Fastest-Growing Region By 2020
Figure 20 North America, an Attractive Destination for Monoclonal Antibodies and Checkpoint Inhibitors
Figure 21 North America: Immunotherapy Drugs Market Snapshot
Figure 22 The Checkpoint Inhibitors Segment is the Fastest-Growing Market Segment in the U.S.
Figure 23 The Monoclonal Antibodies Segment to Dominate the Immunotherapy Drugs Market in Europe During the Forecast Period
Figure 24 APAC: Immunotherapy Drugs Market Snapshot
Figure 25 The Increasing Number of Key Market Players Focusing on Latin American Countries is Driving the Immunotherapy Drugs Market in the RoW Region
Figure 26 Companies Adopted New Product Launches and Approvals as Their Key Growth Strategy Over the Last Three Years
Figure 27 Global Immunotherapy Drugs Market Share Analysis, By Key Player, 2014
Figure 28 Battle for Market Share: Approvals Was the Key Growth Strategy Adopted By Market Players From 2013 to 2015
Figure 29 Geographic Revenue Mix of the Top Four Market Players

Published By: MarketsandMarkets
Product Code: MarketsandMarkets3018


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we´┐Żll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: